Therapeutic Clinical Development Experience and Expertise

A History of Therapeutic Expertise

Developing new drugs to treat human disease is an expensive, complex and time-consuming process. Bringing a new drug to market can take up to 15 years and costs $2.5 billion or more.

Our biopharmaceutical and biotech customers have trusted us to help them advance their trials. Our therapeutic area expertise spans large drug disease markets such as hematology/oncology and chronic conditions along with growing areas of R&D innovation, such as immuno-oncology, cell and gene therapy, biomarkers and rare diseases.

At every stage of the drug development process, PPD deploys the expertise you need to design, plan and execute your clinical trials with skill, precision and unwavering focus on quality.

Explore our therapeutic experience below to learn how PPD can advance your drug development program.

PPD’s Experience in the Past Five Years Supporting

0 +

trials in the past five years

drug approvals globally in 2021¹

drug approvals globally in the past five years¹

of the top 10 selling drugs¹

0 +

countries conducted studies across a wide spectrum of therapeutic areas

Learn more about our therapeutic experience

Biosimilars Development PPD has the proven expertise to help you execute a successful biosimilars program. Learn more about our biosimilars development services. Cardiovascular Experience across a broad range of indications and an investigator network of more than 6,000 cardiologists. Cell and Gene Therapy Capabilities Integrated cell and gene therapy development services from pre-clinical to post-approval. Critical Care We understand the unique nature of clinical studies in a critical care environment and ensure the quality of your development program. Dermatology Experience with dermatology trials ranging from small Phase I studies involving healthy volunteers to large, global, multicenter Phase III trials. Gastroenterology More than 800 clinical development professionals worldwide with experience in gastroenterology protocols. Immunology and Rheumatology PPD's global rheumatology and immunology CRO experience and expert team is one of the worlds best for clinical trials and research. Infectious Diseases PPD Infectious Disease CRO delivers the data you need to support your clinical development strategy. Learn more about the proven clinical expertise of PPD. Metabolic and Endocrine PPD’s endocrinology and metabolic clinical trial experience helps us to manage programs of any size and complexity around the world. Nephrology and Renal Diseases In-depth clinical trial expertise in nephrology and renal disease. Neuroscience Research PPD's neuroscience clinical research team differentiates itself in the field of neuroscience research through a multifaceted therapeutic expertise for CNS clinical trials.  Oncology and Hematology Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network. Ophthalmology Expertise in ophthalmic research, experience with therapeutic-specific ophthalmic vendors and an international network of experienced investigative sites. Pediatrics Learn how PPD uses its expert team of physicians and pediatric specialists to create a meaningful strategy for pediatric therapeutic research. Rare Disease CRO Services PPD is deeply committed to advancing rare disease CRO research. Find out more about our patient-centric solutions that reach globally dispersed populations. Respiratory Experience in conducting Phase I-IV respiratory clinical trials, ranging from a single protocol to full development across a broad range of respiratory indications. Urology PPD has extensive experience in planning and implementing Phase I-IV programs for urology studies in all major markets. Vaccine Development PPD has worked in vaccine development for more than 30 years, offering full-service capabilities. Women’s Health Clinical Trials and Research Our experience in conducting Phase I-IV and consumer health women’s health studies includes thousands of patients and hundreds of sites.